President, dog rescue and TNR organization

Having a chemical solution to replace female spayings would be a total revolution and have a bigger impact; but still, an injectable sterilant for males would be of much help and reduce our costs significantly. We do an average of 2,000  spay/neuterings per year, 35% males. Considering that last year we spent 60,000 euros on anesthetics and medicines (mostly antibiotics), we could save approximately 10,000 euros [approx. $13,000] per year and increase the number of castrations thanks to a quicker procedure.

We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today